ARTICLE
16 November 2015

Initiative Aims To Support Use Of Existing Patient Registries In Clinical Practice

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The patient registry initiative will explore ways of dealing with current challenges faced by companies and regulators in using existing registries and establishing new registries if needed.
European Union Food, Drugs, Healthcare, Life Sciences

EMA has launched an initiative on patient registries aimed at making better use of existing registries as a source of high-quality post-authorization data for regulatory decision-making, and to facilitate the establishment of new registries if needed. Registries collect information over time on patients who are diagnosed with a particular disease or who receive particular treatment. The patient registry initiative will explore ways of dealing with current challenges faced by companies and regulators in using existing registries and establishing new registries if needed.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More